140 related articles for article (PubMed ID: 15108677)
1. Resistance: what are the implications for treatment?
Alcorn K
IAPAC Mon; 2004 Mar; 10(3):76. PubMed ID: 15108677
[No Abstract] [Full Text] [Related]
2. Resistance: a shifting paradigm.
Jenny-Avital ER
AIDS Clin Care; 2002 Dec; 14(12):106. PubMed ID: 12510656
[No Abstract] [Full Text] [Related]
3. Detectable viral loads and slow development of resistance.
Gadd C
IAPAC Mon; 2005 Oct; 11(10):295-6. PubMed ID: 16673496
[No Abstract] [Full Text] [Related]
4. Evolution of protease and reverse transcriptase inhibitor resistance-associated mutations in HIV-1-infected protease inhibitor-treated patients with persistent low viraemia.
Duval X; Descamps D; Breton G; Darmon S; Ecobichon JL; Delarue S; Peytavin G; Leport C; Vildé JL; Brun-Vézinet F
Antivir Ther; 2005; 10(1):197-9. PubMed ID: 15751779
[No Abstract] [Full Text] [Related]
5. Antiretroviral rounds. Resistance: what you don't know--can it hurt you?
Gathe JC; Elion R
AIDS Clin Care; 2008 Jun; 20(6):51-2. PubMed ID: 18661634
[No Abstract] [Full Text] [Related]
6. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?
Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R;
Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
[TBL] 
